Utah lets Nolla Health’s AI issue initial acne prescriptions, the first US state-authorized AI to write new prescriptions, with physician review phased out in stages
Confirmed
The takeaway
On Oct 5, 2026 Nolla Health said its Nolla Derm app is issuing AI-generated initial acne prescriptions to adults in Utah under an agreement with the state’s Office of Artificial Intelligence Policy.
Status
- Claim
Confirmed
- Our reporting
- High confidence
- Importance
- 3 of 5
- Last verified
- 9 October 2026
Your AI and this story
- GPT-6.2 Astra127 days after its cutoff
- Claude Opus 5.597 days after its cutoff
- Gemini 4 Hydrogen188 days after its cutoff
- Grok 4.7127 days after its cutoff
None of these four assistants can know about it. The closest, Claude Opus 5.5, stops 97 days before it.
Key facts
- Scope: mild-to-moderate acne, adults 18+ in Utah, pre-approved topical treatments only (no open-ended prescribing); 10-15 minute intake plus face-scan analysis; $4.99/month pilot price
- Oversight stages (Nolla): stage 1, a physician approves every prescription for the first 100 patients; stage 2, the AI prescribes on its own with daily retroactive physician review up to 500 patients; stage 3, weekly sampled retroactive review
- Nolla claims its AI agrees with licensed clinicians in 96%+ of real-world cases and sends uncertain cases to physicians; patients can message a doctor in the app
- Context: Utah’s average wait for a dermatology appointment is 61 days (Nolla); the app has 175,000+ downloads across 44 states
- People: Nolla co-founder and CEO Luis Wenus; chief medical advisor Dr. Zaid Fadul; Utah OAIP director Zach Boyd quoted in the release
- Nolla has raised $4.5M (investors include General Catalyst), per STAT
- Same day, Utah’s OAIP expanded its health-AI sandbox with more prescription and women’s-health pilots, and agreed with independent third-party evaluators to audit pilots (stress-testing guardrails, inspecting decision logs, checking patient outcomes) in response to critics (STAT)
- Precedent: since Dec 2025/Jan 2026 Utah has let Doctronic’s AI renew chronic-condition prescriptions (190 drugs; physician pre-review in phase 1, retrospective review in phase 2). Nolla’s is the first pilot for initial prescriptions
Show 1 more
- KSL (Oct 6): pilot runs one year; 10,000+ test cases before launch; Utah’s OAIP monitors monthly and Nolla reports patient numbers and outcomes; medical licensing board members helped design it. Fadul said Nolla wants to extend to ages 13+, is exploring birth-control prescriptions and possibly radiology and infections. Boyd: ‘We can let them run a business model that is kind of different from the normal regulations for a little while and try to assess as a state whether we think it could be beneficial’
What happened
Nolla Health announced on Oct 5, 2026 that Nolla Derm, its acne app, now issues AI-generated initial prescriptions to Utah residents aged 18 and over. This runs under a regulatory agreement with Utah’s Office of Artificial Intelligence Policy (OAIP), which can waive state rules for supervised AI pilots, and was coordinated with the Utah Medical Board. Patients complete an intake questionnaire and a face scan. The AI chooses only from pre-approved topical treatments, and cases it is unsure about go to physicians.
Human sign-off is removed in stages. A physician approves every prescription for the first 100 patients. Up to 500 patients, the AI prescribes on its own and a physician reviews the decisions daily. After that, review falls to weekly samples. Bloomberg (paywalled, seen only as a headline summary) called it a first-of-its-kind US pilot of AI diagnosing and prescribing without direct human oversight.
STAT reported that the same day the OAIP expanded its health sandbox with more prescription and women’s-health pilots, and, answering critics, signed up independent evaluators to audit the pilots.
Why it matters
Utah had already let Doctronic’s AI renew existing prescriptions (from Dec 2025/Jan 2026). Nolla’s pilot moves state-sanctioned autonomous AI to new diagnoses and first prescriptions, a step US medical boards have so far reserved for licensed clinicians. The staged removal of human review and the third-party audits make it a test case for other states and for the FDA/state-licensing debate. The 96% agreement figure is the company’s own and has not been independently verified.
Sources
11 sources from 10 sites. Numbers match the chips in the text.
11 sources: 3 primary, 7 press, 1 reaction
Primary
- Nolla Health press release: Nation’s first AI to issue initial prescriptions (PR Newswire, Oct 5, 2026)prnewswire.com, official
- Utah Department of Commerce: Utah and Doctronic partnership for AI prescription renewals (Jan 6, 2026)commerce.utah.gov, official
- Utah OAIP: Doctronic outcomes, May 2026 (PDF)commerce.utah.gov, official
Press
- Bloomberg: Nolla Health AI can now prescribe acne drugs in Utah without doctorsbloomberg.com, press
- The Verge: This startup is issuing AI-generated acne prescriptionstheverge.com, press
- KSL: Utah pilot lets artificial intelligence prescribe acne treatmentsksl.com, press
- STAT: Utah expands AI sandbox with more pilots for prescriptions, women’s health (partly paywalled)statnews.com, press
- Unite.AI: Nolla Health launches AI-issued initial acne prescriptions in Utahunite.ai, press
- Hoodline: Utah lets AI prescribe acne drugs with no doctor signing offhoodline.com, press
- ABC News: Medical company announces program for ‘AI-powered prescriptions’ in Utah (Oct 7)abcnews.com, press
Reactions
Changes
- Added ABC News coverage
- Added Bloomberg, The Verge and KSL coverage; KSL details on monitoring, test cases and expansion plans
- Linked the new Doctronic precedent entry (Utah lets Doctronic’s AI renew chronic-condition prescriptions, the first US state-sanctioned AI role in prescribing)
- Filed (Nolla press release, STAT, Unite.AI, Hoodline; Utah OAIP site returned 403, so the Doctronic background comes from the Jan 2026 Utah release and search summaries)